Company profile for Matica Biotechnology

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Matica Biotechnology, Inc. is a contract development and manufacturing organization (CDMO) specializing in the production of virus-based cell & gene therapeutics, oncolytic vectors and vaccines for our clients. Supported by our parent company, CHA Biotech, our new GMP facility in College Station, TX provides comprehensive support for your virus products.Our LENTIVIRUS and AAV manufacturing platforms have been designed to strea...
Matica Biotechnology, Inc. is a contract development and manufacturing organization (CDMO) specializing in the production of virus-based cell & gene therapeutics, oncolytic vectors and vaccines for our clients. Supported by our parent company, CHA Biotech, our new GMP facility in College Station, TX provides comprehensive support for your virus products.Our LENTIVIRUS and AAV manufacturing platforms have been designed to streamline the CMC development cycle by optimizing biological components, processes and documentation to maximize titers, minimize impurities, and mitigate technical and regulatory risks.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2501 Earl Rudder Freeway, College Station, TX
Telephone
Telephone
+1 979-321-7500
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

Global ChemShow

Not Confirmed

envelop Contact Supplier

Global ChemShow

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/matica-bio-a-cdmo-leader-in-oncolytic-virus-manufacturing-partners-with-calidi-biotherapeutics-to-advance-calidis-project-toward-ind-302600781.html

PR NEWSWIRE
03 Nov 2025

https://www.prnewswire.com/news-releases/matica-biotechnology-emerges-as-the-go-to-cdmo-for-cell--gene-therapy-in-2025-302575043.html

PR NEWSWIRE
06 Oct 2025

https://www.prnewswire.com/news-releases/matica-bio-secures-commercial-manufacturing-deal-with-us-biotech-company-302555419.html

PR NEWSWIRE
15 Sep 2025

https://www.prnewswire.com/news-releases/matica-biotechnology-and-cirsium-biosciences-announce-aav-manufacturing-collaboration-302548482.html

PR NEWSWIRE
08 Sep 2025

https://www.contractpharma.com/breaking-news/matica-biotechnology-texas-ams-nctm-partner-to-support-cgt-developers/

CONTRACTPHARMA
05 May 2025

https://www.businesswire.com/news/home/20241204005498/en

BUSINESSWIRE
04 Dec 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty